Practice Essentials for Using Immune Checkpoint Inhibitors to Treat Lung Cancer and Melanoma

An Educational Initiative for Pharmacists and Physicians

About the Series

This educational activity will explore the evolving issues, key questions and controversies associated with the use of immunotherapies for the treatment of patients with melanoma and lung cancer. Discussion will include an overview of cancer immunobiology, available and emerging immune checkpoint inhibitors, clinical efficacy and safety experience, current and expanding indications, rationale and evidence for combination therapies. The use of biomarkers to predict response, management of immune-related adverse events, and patient education will also be explored. Patient cases will be used to highlight therapy selection as well as adverse effects and toxicity management strategies.

   Part 1: Live Symposium & Webinar

Practice Essentials for Using Immune Checkpoint Inhibitors to Treat Lung Cancer and Melanoma

Tuesday, December 10, 2019, 11:30 AM - 1:00 p.m. PT

Islander Ballroom I, Lower Level, Mandalay Bay North Convention Center
Las Vegas, Nevada

  Part 2: Ask the Experts Webinar

Wednesday, March 25, 2020, 1:00 - 2:00 p.m. ET

This reinforcement activity features pharmacist and physician faculty continuing the discussion from Part 1 and addressing additional questions posed by learners.



  Part 3: Engaging the Experts

Listen to interviews with faculty on key topics via podcast or on the activity website.